BrainScan is a medical company that has developed an AI-based system for head CT scan analysis. The company has amassed a global collection of CT scans, comprising 250,000 head CT scans along with radiologists’ reports (approximately 12.5 million scans). The company says the collected scans are diverse in individual characteristics and come from 21 different CT scanner models, allowing the creation of an AI model with high efficacy metrics.
Currently, the BrainScan CT system can detect 30 of the most common brain pathologies, including hemorrhages, tumors, and traumatic brain injuries, pinpointing the location of the changes. It is also compatible with all hospital systems – DICOM, PACS, RIS/HIS.
“After a very intense 2023, during which we obtained CE MDR certification, opening the possibility of deploying our system in the European market, and obtaining certifications for the UK, Swiss, Moroccan, and Ukrainian markets, it is now time to strengthen the company’s position in additional markets. Besides continuing collaborations with current entities, we aim to expand our system’s reach in other countries across Europe, Africa, and the Middle East,” said Dr. Szymon Korzekwa, CEO of BrainScan SA.
“Our solution, BrainScan CT, provides doctors with an analysis result within 3 minutes, which – according to analyses conducted in the Emergency Department of the Regional Hospital in Poznan – leads to a reduction in patient transfer time to the ward by 69 minutes in the case of undetermined stroke (non-hemorrhagic or infarct), 66 minutes in the case of intracranial hemorrhage, and 33 minutes in the case of intracranial injury.
This is crucial for efficient patient triage, allowing almost immediate response in urgent cases. The system can also support the work of less experienced doctors, serve as a ‘second pair of eyes’ during long shifts, and reduce the risk of missing pathologies by doctors, which brings significant benefits – both for patient health and economically for the facility,” added the company’s president.
As part of humanitarian aid to Ukraine, based on an agreement with the Ministry of Health of Ukraine, the company’s system also operates in the most needed regions of the country, supporting the work of radiologists in Odessa, Rozdilna, and Kramatorsk. In the first quarter of 2024, an agreement was signed, and the system was launched at the Regional Clinical Hospital in Zhytomyr.
In the sales domain, BrainScan collaborates with distributors such as Novotika (Bulgaria), HCK (Morocco), Datamed (Lithuania), Milvue (France), Aplicaciones Tecnológicas (Spain), and Pearl Innovision (Switzerland). The solution is also available on major marketplaces: TestDynamic (USA), CARPL (USA), deepc (Europe), and NEOS and ADS (India).
The system developed by the Polish company has been recognised multiple times by experts – both in Europe and globally. This is confirmed by awards such as the Gold Medal of the Radiological Society of North America in Chicago, second place in the AI Theater European Society of Radiology competition in Vienna, and first place at this year’s Expand North Star trade fair in Dubai. The company presented its solution during the European Congress of Radiology, which allowed it to gather valuable market feedback, confirm the demand for its solution, and acquire new business contacts.
As of May 15, 2024, BrainScan SA shares are listed on the NewConnect Warsaw Stock Exchange.
